These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22390545)

  • 1. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis.
    Ercan A; Cui J; Hazen MM; Batliwalla F; Royle L; Rudd PM; Coblyn JS; Shadick N; Weinblatt ME; Gregersen P; Lee DM; Nigrovic PA
    Arthritis Res Ther; 2012 Mar; 14(2):R43. PubMed ID: 22390545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
    Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI
    Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis.
    Troelsen LN; Jacobsen S; Abrahams JL; Royle L; Rudd PM; Narvestad E; Heegaard NH; Garred P
    J Rheumatol; 2012 Mar; 39(3):463-9. PubMed ID: 22247351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
    Barrera P; van der Maas A; van Ede AE; Kiemeney BA; Laan RF; van de Putte LB; van Riel PL
    Rheumatology (Oxford); 2002 Apr; 41(4):430-9. PubMed ID: 11961174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    J Rheumatol; 2012 Jul; 39(7):1341-7. PubMed ID: 22660798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
    Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
    J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate.
    Gińdzieńska-Sieśkiewicz E; Radziejewska I; Domysławska I; Klimiuk PA; Sulik A; Rojewska J; Gabryel-Porowska H; Sierakowski S
    Adv Med Sci; 2016 Sep; 61(2):193-197. PubMed ID: 26876088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial.
    Taylor PC; Saurigny D; Vencovsky J; Takeuchi T; Nakamura T; Matsievskaia G; Hunt B; Wagner T; Souberbielle B;
    Arthritis Res Ther; 2019 Apr; 21(1):101. PubMed ID: 30999929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.
    Ercan A; Cui J; Chatterton DE; Deane KD; Hazen MM; Brintnell W; O'Donnell CI; Derber LA; Weinblatt ME; Shadick NA; Bell DA; Cairns E; Solomon DH; Holers VM; Rudd PM; Lee DM
    Arthritis Rheum; 2010 Aug; 62(8):2239-48. PubMed ID: 20506563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
    Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
    Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.
    Wampler Muskardin T; Vashisht P; Dorschner JM; Jensen MA; Chrabot BS; Kern M; Curtis JR; Danila MI; Cofield SS; Shadick N; Nigrovic PA; St Clair EW; Bingham CO; Furie R; Robinson W; Genovese M; Striebich CC; O'Dell JR; Thiele GM; Moreland LW; Levesque M; Bridges SL; Gregersen PK; Niewold TB
    Ann Rheum Dis; 2016 Oct; 75(10):1757-62. PubMed ID: 26546586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate chronotherapy is effective against rheumatoid arthritis.
    To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
    Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
    Bondt A; Hafkenscheid L; Falck D; Kuijper TM; Rombouts Y; Hazes JMW; Wuhrer M; Dolhain RJEM
    Ann Rheum Dis; 2018 Aug; 77(8):1130-1136. PubMed ID: 29615411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of high levels of soluble tumour necrosis factor-α receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort study.
    Cañete JD; Albaladejo C; Hernández MV; Laínez B; Pinto JA; Ramírez J; López-Armada MJ; Rodríguez-Cros JR; Engel P; Blanco FJ; Sanmartí R
    Rheumatology (Oxford); 2011 Apr; 50(4):721-8. PubMed ID: 21134963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
    Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
    J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS
    Sun D; Hu F; Gao H; Song Z; Xie W; Wang P; Shi L; Wang K; Li Y; Huang C; Li Z
    Analyst; 2019 Mar; 144(6):2042-2051. PubMed ID: 30714583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.